Jun 16, 2022 / 02:00PM GMT
Silvan Türkcan - JMP Securities LLC - Analyst
Welcome back to the JMP Life Sciences Conference, the second day. My name is Silvan Türkcan. I'm a senior analyst covering precision medicines here. It's my pleasure to host Cellectis at today's conference. André Choulika, CEO and Founder; and Arthur Stril, Chief Business Officer. Thank you. Thanks for joining us today.
AndréChoulika - Cellectis SA - CEO & Board Director
Thanks for inviting us.
Arthur Stril - Cellectis SA - Chief Business Officer
Thanks for inviting us.
Questions and Answers:
Silvan Türkcan - JMP Securities LLC - AnalystSo, obviously, maybe we could start with your view about the allogeneic CAR T space coming out of all the data sets that we've seen at ACR, EHA, ASCO. The recent days, there have been a lot of updates. So can you just tell us how -- where are we now with ALLO?
AndréChoulika - Cellectis SA - CEO & Board Director<